The Urinary Incontinence market report provides current treatment practices, emerging drugs, Urinary Incontinence market share of the individual therapies, current and forecasted Urinary Incontinence market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Urinary Incontinence treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Urinary Incontinence Overview
Urinary incontinence, which is also known as the loss of bladder control is a common problem in which a person leaks urine by chance. Although, it may happen to anyone but older people specially women are severely affected by this problem. Urinary incontinence is not just a health problem, it can affect emotional, psychological and social life. Many people who have urinary incontinence are anxious to do normal daily events. They do not want to be too distant from a toilet. Urinary incontinence can keep people from enjoying life.
Request free sample copy- https://www.delveinsight.com/sample-request/urinary-incontinence-market
List of regions covered in the report
List of companies involved in the report
Urinary Incontinence Types
Types of urinary incontinence include stress incontinence, urge incontinence, and overflow incontinence, functional incontinence, and mixed incontinence. Urinary incontinence is not a disease, it is a symptom. It can be caused by everyday habits, underlying medical conditions or physical problems. Certain drinks, foods, and medications may act as diuretics which stimulates the individual’s bladder; increasing the volume of urine. They include alcohol, caffeine, carbonated drinks, sparkling water, artificial sweeteners, chocolate, and large doses of vitamin C, among others.
Urinary Incontinence Causes
It may also be caused by some easily treatable medical conditions, such as first urinary tract infection which can irritate the person’s bladder and cause strong urge to urinate. And, constipation in this condition hardens, compacts stool in the individual’s rectum, causing the nerves to be overactive and increasing the urinary frequency.
Urinary Incontinence Market Outlook
Urinary Incontinence market is segmented into behavioral techniques, muscle exercises, electrical stimulation, medications, and interventional therapies, among others. However, treatment for urinary incontinence depends on the type of incontinence, its severity, and the underlying cause. The therapeutic modalities have been designed based on a better understanding of the pathogenesis of Urinary Incontinence.
Urinary Incontinence Treatment Market
For the treatment of urinary incontinence, doctors might suggest behavioral techniques, such as bladder training to delay the urination, double voiding to empty the patient’s bladder completely, scheduling of toilet trips, and fluid and diet management, among others. In muscle exercises, doctors recommend exercises of tightening (contract) of the muscles, person would use to stop urinating and hold for 5 s, and then relax for 5.
Urinary Incontinence Therapeutic Market
The current therapeutic market of Urinary Incontinence is dependent on both the marketed as well as generic products. Some of the common medications used to treat urinary incontinence include anticholinergics which include oxybutynin (Ditropan XL), tolterodine (Detrol), darifenacin (Enablex), fesoterodine (Toviaz), solifenacin (Vesicare), and trospium (Sanctura). Additionally, Mirabegron (Myrbetriq) which is used to treat urge incontinence relaxes the bladder muscle and can increase the amount of urine individual’s bladder can hold. Also, the alpha-blocker includes tamsulosin (Flomax), alfuzosin (Uroxatral), silodosin (Rapaflo), doxazosin (Cardura) and terazosin, and topical estrogen.
Urinary Incontinence Factors
The other factors that shall further expedite the growth of the Urinary Incontinence market include high prevalence of the disease, increasing the geriatric population, and increasing awareness about available treatments during the forecast period (2020–2030). A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Urinary Incontinence.
Urinary Incontinence Market Report Scope
Table of content
1. Key Insights
2. Executive Summary of Urinary Incontinence
3. Competitive Intelligence Analysis for Urinary Incontinence
4. Urinary Incontinence: Market Overview at a Glance
5. Urinary Incontinence: Disease Background and Overview
6. Patient Journey
7. Urinary Incontinence Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Urinary Incontinence Treatment
11. Marketed Products
12. Emerging Therapies
13. Urinary Incontinence: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Urinary Incontinence
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Urinary Incontinence Market Report Highlights
Why should you buy this report?
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/